Related Experiment Videos
Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta
B Razani1, X L Zhang, M Bitzer
1Department of Molecular Pharmacology and The Albert Einstein Cancer Center and the Departments of Medicine and Molecular Genetics, Albert Einstein College of Medicine, Bronx, New York 10461.
Abstract:
Transforming growth factor-beta (TGF-beta) signaling proceeds from the cell membrane to the nucleus through the cooperation of the type I and II serine/threonine kinase receptors and their downstream SMAD effectors. Although various regulatory proteins affecting TGF-beta-mediated events have been described, relatively little is known about receptor interactions at the level of the plasma membrane. Caveolae are cholesterol-rich membrane microdomains that, along with their marker protein caveolin-1 (Cav-1), have been implicated in the compartmentalization and regulation of certain signaling events. Here, we demonstrate that specific components of the TGF-beta cascade are associated with caveolin-1 in caveolae and that Cav-1 interacts with the Type I TGF-beta receptor. Additionally, Cav-1 is able to suppress TGF-beta-mediated phosphorylation of Smad-2 and subsequent downstream events. We localize the Type I TGF-beta receptor interaction to the scaffolding domain of Cav-1 and show that it occurs in a physiologically relevant time frame, acting to rapidly dampen signaling initiated by the TGF-beta receptor complex.
Insights
Caveolin-1 (Cav-1) in caveolae interacts with the Type I TGF-beta receptor, suppressing downstream signaling. This interaction rapidly dampens transforming growth factor-beta (TGF-beta) pathway activation at the plasma membrane.
Area of Science:
- Cell Biology
- Molecular Signaling
- Membrane Biology
Background:
- Transforming growth factor-beta (TGF-beta) signaling is crucial for cellular processes, involving membrane receptors and SMAD proteins.
- Regulation of TGF-beta receptor interactions at the plasma membrane remains incompletely understood.
- Caveolae, cholesterol-rich microdomains marked by caveolin-1 (Cav-1), are known regulators of cell signaling.
Purpose of the Study:
- To investigate the role of caveolin-1 (Cav-1) and caveolae in the regulation of transforming growth factor-beta (TGF-beta) signaling.
- To identify specific interactions between TGF-beta pathway components and Cav-1 within caveolae.
- To determine the functional consequences of Cav-1 association with the TGF-beta receptor complex.
Main Methods:
- Co-immunoprecipitation to assess protein-protein interactions between Cav-1 and TGF-beta receptor components.
- Cellular localization studies to determine the presence of TGF-beta pathway elements within caveolae.
- Western blotting to analyze Smad-2 phosphorylation levels in response to TGF-beta stimulation and Cav-1 presence.
Main Results:
- Specific components of the TGF-beta signaling pathway were found to associate with caveolin-1 (Cav-1) within caveolae.
- Cav-1 directly interacts with the Type I TGF-beta receptor at the plasma membrane.
- Cav-1 binding suppresses TGF-beta-induced Smad-2 phosphorylation and downstream signaling events, localizing to the Cav-1 scaffolding domain.
Conclusions:
- Caveolin-1 (Cav-1) plays a direct inhibitory role in transforming growth factor-beta (TGF-beta) signaling by interacting with the Type I TGF-beta receptor.
- This interaction within caveolae provides a mechanism for rapid dampening of TGF-beta-initiated signaling at the cell surface.
- The findings elucidate a novel regulatory checkpoint for TGF-beta pathway activation mediated by membrane microdomains.